Zdravlje a.d.
Marko Matovic is an accomplished legal professional with extensive experience in various high-profile positions within the legal and compliance sectors. Currently serving as the Legal and Compliance Director at Zdravlje Leskovac since May 2021, Marko previously held the role of Legal Affairs Manager at the same company. Marko has also worked as Head of Legal at United Media and as a Senior Associate at Mihaj, Ilić & Milanović Law Firm. Other notable roles include Associate in Competition Law at Karanovic & Nikolic Law Firm and Attorney at Law during a secondment at Valeant Pharmaceuticals. Marko's academic credentials include a Specialist Degree in Pharmaceutical Marketing and Management from the University of Belgrade's Faculty of Pharmacy, alongside a law degree from the University of Belgrade Faculty of Law. Additionally, Marko has studied at Masaryk University in Brno and completed secondary education at V beogradska gimnazija.
Previous companies
This person is not in any teams
This person is not in any offices
Zdravlje a.d.
Pharmaceutical and Chemical Industry Zdravlje Leskovac is a leader in the Balkan pharmaceutical industry. Zdravlje, which is a Serbian word for “Health”, has a 70-year-long history of manufacturing first-class pharmaceutical products at the highest international standards. From April the 1st 2021, Zdravlje continues its journey as an independent pharmaceutical company under the ownership of Frontier Pharma and Baystone Group, highly experienced UK-based pharmaceutical investors and entrepreneurs. Founded in 1953 by a small group of enthusiastic pharma professionals, Zdravlje’s history is filled with seven decades of production, marketing, and sales worldwide, as well as successful cooperation with the biggest names in the industry like BOEHRINGER, PFIZER, LEDERLE, CLIN MYDI, WELLCOMME, MADAUS, GRÜNENTHAL, Dr DRALLE, SCHWARZKOPF, TRAVENOL, POLYMER TECHNOLOGY... After almost two decades working as a part of Actavis and Teva, launching a new facility in compliance with EU GMP and EHS standards, and receiving several awards in the category of the best quality and performance manufacturing site, from April the 1st 2021, Zdravlje formally starts to operate under the ownership of Frontier Pharma and Baystone Group as an independent pharmaceutical company and a Balkan leader in this industry.